Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Oxervate Market Growth Potential: How Will Market Size Shift Through 2030?
The historical growth was spurred by the escalating diagnosis of neurotrophic keratitis, the scarcity of potent corneal repair treatments, breakthroughs in recombinant protein development, enhanced access to specialized ophthalmology care, and the receipt of regulatory approvals for orphan drugs.
The anticipated growth during the forecast period is primarily driven by the expanding research in regenerative ophthalmology, increased investments in treatments for rare eye diseases, the wider embrace of biologics in ophthalmologic care, heightened awareness among eye care professionals, and the widening reach of specialty pharmacy distribution. Significant trends expected throughout the forecast period involve the growing acceptance of recombinant growth factor therapies, a concentrated effort on rare ophthalmic disease treatments, the development of targeted corneal regeneration solutions, an increased focus on precision in biologics manufacturing, and improved cold-chain management for biologic eye drops.
Get A Free Sample Report With In-Depth Market Insights:
Oxervate Market Growth Factors Behind Sustained Expansion
The oxervate market is anticipated to expand due to the rising occurrence of eye inflammation disorders. These conditions manifest as swollen and irritated eye tissues, frequently leading to discomfort, redness, and impaired vision. Their escalation is linked to elements like environmental pollution, prolonged screen exposure, allergic reactions, and an expanding elderly demographic. Oxervate addresses these disorders by supplying a recombinant nerve growth factor (NGF), which facilitates corneal tissue repair, diminishes inflammation, and enhances nerve function, thereby assisting in re-establishing the eye’s natural protective layer. As an illustration, GOV.UK, a UK government website, reported in May 2024 that England saw more than 8.9 million vision outpatient visits in the financial year ending 2023, equivalent to 15,362 per 100,000 population, marking an increase from the preceding year. Consequently, the increasing prevalence of eye inflammation disorders is stimulating the growth of the oxervate market. The expanding older adult demographic is anticipated to fuel the future expansion of the oxervate market. This demographic comprises individuals 65 years and above, generally in later life stages and frequently confronting health issues associated with aging. This increase stems from progress in healthcare, enhanced living conditions, and wider availability of medical care. Oxervate provides advantages to older individuals by fostering corneal nerve regeneration and lowering the risk of corneal harm in those with neurotrophic keratitis, a condition prevalent among the elderly due to age-related shifts in the nervous system. For example, the UK Parliament’s House of Commons Library reported in July 2024 that in 2022, 12.7 million individuals in the UK were 65 or older, making up 19% of the total population. This number is predicted to climb to 22.1 million by 2072, accounting for 27% of the nation’s populace. Thus, the increasing geriatric population is propelling the growth of the oxervate market.
Oxervate Market Segment Breakdown: Which Categories Lead On Revenue?
The oxervate market covered in this report is segmented –
1) By Clinical Indication: Neurotrophic Keratitis, Dry Eye Disease (DED)
2) By Distribution Channel: Retail Pharmacies, Online Pharmacies
3) By End User: Hospitals, Ophthalmology Clinics, Home Care
Oxervate Market Leading Players And Competitive Positioning
Major companies operating in the oxervate market are Dompé Farmaceutici S.p.A.
View The Full Oxervate Market Report:
Oxervate Market Regional Distribution: Which Areas Power Market Growth?
North America was the largest region in the oxervate market in 2025. The regions covered in the oxervate market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
